Jessica Cortazzo, Ivims Medical Director and a diplomate of the American Board of Obesity Medicine (ABOM), went on to highlight, Our approach to medical weight loss utilizes customized GLP-1 care plans that significantly improve employee biomarkers, enhance employee well-being, engagement, and company performance, while also providing significant cost savings through claims reductions and rebate programs to both employers and employees
Get started In clinical trials of the oral Wegovy (semaglutide) pill, participants taking the medication with diet and exercise achieved average weight loss of about 14%17% over ~64 weeks compared with ~2% with placebo
Cifuentes M, Del Barrio-Daz P, Vera-Kellet C
03.01.22 Warning label updated Ozempics warning label was updated to include gallbladder disease
The health economic evaluation of bariatric surgery versus a community weight management intervention analysis from the idiopathic intracranial hypertension weight trial (IIH:WT)
